Now Reading: CureBay raises ₹100 cr to expand rural clinics, add AI
-
01
CureBay raises ₹100 cr to expand rural clinics, add AI
The Story in Brief
Healthtech startup CureBay has raised around ₹100 crore in a pre-Series C round, with over ₹69 crore in equity led by IvyCap Ventures and ₹30 crore in debt from Trifecta Capital, Alteria Capital and VentureSoul Partners. Co-founder and CEO Priyadarshi Mohapatra said the funds will be used to expand into Andhra Pradesh and Telangana, strengthen its AI screening products, and grow its network of rural clinics from 250 to 800 over the next two to three years.
The startup closed FY26 with an annual recurring revenue of nearly ₹170 crore and aims to double that in FY27 while maintaining an operating EBITDA break-even. CureBay claims to have served over 12 lakh patients across 4,500 pincodes in Odisha, Chhattisgarh, Jharkhand and Bihar. The company remains loss-making at the company level but expects profitability once it reaches a stable operating scale.
Indian Opinion Analysis
Both inc42 and ET report the ₹100 Cr pre-Series C round for CureBay with near-identical details: equity led by IvyCap Ventures and debt from Trifecta Capital, Alteria Capital and VentureSoul Partners. Inc42 provides fuller operational figures, including ARR of ₹170 Cr for FY26, the target to double that in FY27 and the aim to break even at an EBITDA level. ET focuses more tightly on the fundraise and expansion into Andhra Pradesh. Neither outlet carries government-critical or pro-government framing, the coverage is uniformly straight reporting from the startup’s own disclosures. The key open point is whether CureBay can double its ARR and sustain operating EBITDA gains while entering loss-making new geographies.
Coverage: 2 sources, 2 neutral
Sources (2): inc42.com (neutral report), economictimes.indiatimes.com (neutral report)
This brief was synthesised by AI from the 2 sources linked above, so one read covers every framing they carry. Methodology and corrections.
